|
1
|
Yi Y, Wang L, Zhao D, Huang S, Wang C, Liu Z, Sun H, Liu K, Ma X, Li Y. Structural optimization of diphenylpyrimidine scaffold as potent and selective epidermal growth factor receptor inhibitors against L858R/T790M resistance mutation in nonsmall cell lung cancer. Chem Biol Drug Des 2018; 92:1988-1997. [PMID: 30030903 DOI: 10.1111/cbdd.13370] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2017] [Revised: 04/08/2018] [Accepted: 06/25/2018] [Indexed: 12/27/2022]
Affiliation(s)
- Yuanyuan Yi
- Department of Respiratory Medicine; The First Affiliated Hospital of Dalian Medical University; Dalian China
| | - Luhong Wang
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Dan Zhao
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Shanshan Huang
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Changyuan Wang
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Zhihao Liu
- College of Pharmacy; Dalian Medical University; Dalian China
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines; Institute of Materia Medica; Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China
| | - Huijun Sun
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Kexin Liu
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Xiaodong Ma
- College of Pharmacy; Dalian Medical University; Dalian China
| | - Yanxia Li
- Department of Respiratory Medicine; The First Affiliated Hospital of Dalian Medical University; Dalian China
| |
Collapse
|